ANDA Litigation Settlements

Spring 2014

GENERICally Speaking
Case Name Drug Patent No(s). Publicly Available Terms

Merck Sharp & Dohme Corp. Aurobindo Pharma. Ltd., 13-5442 (D.N.J.)

Sustiva® (efavirenz)

6,639,071
6,673,372
6,939,964

N/A

Noven Pharma. v. Watson Labs. Inc., 11-5997 (D.N.J.)

Daytrana® (methylphenidate transdermal system)

6,348,211

Noven will grant Shire PLC a nonexclusive, royalty-bearing license to market generic methylphenidate transdermal patches beginning in September 2015, or earlier under certain unspecified conditions.


Back to Top